Acta Pharmacologica Sinica, 2022 · DOI: https://doi.org/10.1038/s41401-021-00759-5 · Published: January 1, 2022
Spinal cord injury (SCI) is a severe trauma that can disrupt nerve function. This study focuses on how metformin, a common diabetes drug, can aid in nerve repair after SCI by helping to clear away damaged myelin, which is essential for nerve function. The researchers found that metformin promotes a specific type of immune cell (microglia) to clear myelin debris more effectively. It does this by influencing the microglia to switch from an inflammatory state (M1) to a repair state (M2), which is crucial for nerve regeneration. Additionally, metformin was found to enhance autophagy, a cellular cleaning process, in these microglia cells. This process helps remove damaged components and promotes nerve recovery after SCI.
Metformin may be a potential therapeutic agent for promoting nerve repair and functional recovery after spinal cord injury.
Targeting microglial polarization and autophagy could be a promising strategy for treating SCI and other neurological disorders.
Enhancing autophagy in microglial cells can promote myelin debris clearance and improve nerve regeneration after SCI.